ѻý

<ѻý class="page-title">Meeting Coverage

GuCS Video Pearls

<ѻý class="page-description">Video Pearls from the Genitourinary Cancers Symposium
Study Tests Office-Based Transperineal Approach to Prostate Biopsies

Antibiotic-free option resulted in zero infections in randomized trial

image
<ѻý class="section_title">Latest GuCS Video Pearls Meeting Coverage
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC

A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD

February 22, 2024
More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancer

BRCAAway trial confirms role of combination in first-line setting

February 15, 2024
Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies

Multiparametric blood test demonstrated superior specificity to standard PSA testing

February 9, 2024
Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer

Tanya Jindal discusses findings from the UNITE study

March 23, 2023
Adding Pembrolizumab to Docetaxel Fails to Improve Survival in mCRPC

Daniel Petrylak, MD, discusses efficacy and safety data from KEYNOTE-921 trial

March 16, 2023
Novel Gene Tx Shows Early Promise in BCG-Unresponsive Bladder Cancer

First step toward replacing BCG therapy, says Gary Steinberg, MD

March 9, 2023
The Current State of Muscle-Invasive Bladder Cancer Management

Shilpa Gupta, MD, reviews current therapies and previews the next steps in optimizing survival

March 2, 2023